Volatile constituents of Notobubon and Nanobubon (Apiaceae, tribe Tordylieae)
The essential oil composition and headspace volatiles from the aerial parts of the genera Notobubon and Nanobubon are reported for the first time. Eleven of the thirteen Notobubon and two of the three Nanobubon species were studied. Oil yields obtained by hydro-distillation ranged from 0.1 to 3.6% of dry weight. Forty-four compounds representing 63.8-96.8% of the total oil were identified from the essential oil of eight species of Notobubon and one species of Nanobubon by GC/MS-FID. p-Cymene was present in all samples of Notobubon but not detected in Nanobubon. GC/GC-ToF-MS headspace analysis of eleven species of Notobubon showed α-pinene (1-48%), β-pinene (2-31%), p-cymene (1-41%), sabinene (1-27%), α-thujene (1-22%), and in one species estragole (78-97%) as the main compounds, while in Nanobubon myrcene (1-37%), limonene (13-30%), 3-methyl-2-methylene-butanenitrile (0-27%), sabinene (1-26%) and α-pinene (1-25%) were identified as major constituents..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
The journal of essential oil research - 29(2017), 4, Seite 289-10 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sobiyi, Oluwakemi K [VerfasserIn] |
---|
Links: |
---|
BKL: | |
---|---|
Themen: |
Apiaceae |
doi: |
10.1080/10412905.2016.1259664 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC199513189X |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC199513189X | ||
003 | DE-627 | ||
005 | 20230518003036.0 | ||
007 | tu | ||
008 | 170721s2017 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1080/10412905.2016.1259664 |2 doi | |
028 | 5 | 2 | |a PQ20171228 |
035 | |a (DE-627)OLC199513189X | ||
035 | |a (DE-599)GBVOLC199513189X | ||
035 | |a (PRQ)c1381-ef13bf9f7ae1d41407b0f3355f41d4160673bd612684024755cb1700e0ab611f0 | ||
035 | |a (KEY)0179091920170000029000400289volatileconstituentsofnotobubonandnanobubonapiacea | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 660 |q DE-600 |
084 | |a PHARM |2 fid | ||
084 | |a 44.40 |2 bkl | ||
100 | 1 | |a Sobiyi, Oluwakemi K |e verfasserin |4 aut | |
245 | 1 | 0 | |a Volatile constituents of Notobubon and Nanobubon (Apiaceae, tribe Tordylieae) |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a The essential oil composition and headspace volatiles from the aerial parts of the genera Notobubon and Nanobubon are reported for the first time. Eleven of the thirteen Notobubon and two of the three Nanobubon species were studied. Oil yields obtained by hydro-distillation ranged from 0.1 to 3.6% of dry weight. Forty-four compounds representing 63.8-96.8% of the total oil were identified from the essential oil of eight species of Notobubon and one species of Nanobubon by GC/MS-FID. p-Cymene was present in all samples of Notobubon but not detected in Nanobubon. GC/GC-ToF-MS headspace analysis of eleven species of Notobubon showed α-pinene (1-48%), β-pinene (2-31%), p-cymene (1-41%), sabinene (1-27%), α-thujene (1-22%), and in one species estragole (78-97%) as the main compounds, while in Nanobubon myrcene (1-37%), limonene (13-30%), 3-methyl-2-methylene-butanenitrile (0-27%), sabinene (1-26%) and α-pinene (1-25%) were identified as major constituents. | ||
540 | |a Nutzungsrecht: © 2016 Informa UK Limited, trading as Taylor & Francis Group 2016 | ||
650 | 4 | |a Nanobubon | |
650 | 4 | |a essential oil composition | |
650 | 4 | |a Umbelliferae | |
650 | 4 | |a Apiaceae | |
650 | 4 | |a Notobubon | |
650 | 4 | |a headspace volatiles | |
700 | 1 | |a Kamatou, Guy P. P |4 oth | |
700 | 1 | |a Viljoen, Alvaro M |4 oth | |
700 | 1 | |a Magee, Anthony R |4 oth | |
700 | 1 | |a Van Wyk, Ben-Erik |4 oth | |
773 | 0 | 8 | |i Enthalten in |t The journal of essential oil research |d London [u.a.] : Taylor & Francis, 1989 |g 29(2017), 4, Seite 289-10 |w (DE-627)130796026 |w (DE-600)1007064-3 |w (DE-576)435516957 |x 1041-2905 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2017 |g number:4 |g pages:289-10 |
856 | 4 | 1 | |u http://dx.doi.org/10.1080/10412905.2016.1259664 |3 Volltext |
856 | 4 | 2 | |u http://www.tandfonline.com/doi/abs/10.1080/10412905.2016.1259664 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-TEC | ||
912 | |a SSG-OLC-CHE | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-FOR | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a SSG-OPC-PHA | ||
936 | b | k | |a 44.40 |q AVZ |
951 | |a AR | ||
952 | |d 29 |j 2017 |e 4 |h 289-10 |